SoftOx Solutions AS (SOFTX) - Total Assets
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) holds total assets worth Nkr33.93 Million NOK (≈ $3.57 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SoftOx Solutions AS (SOFTX) share price today for real-time trading data and today's change.
SoftOx Solutions AS - Total Assets Trend (2016–2025)
This chart illustrates how SoftOx Solutions AS's total assets have evolved over time, based on quarterly financial data. Also see cash efficiency ratio of SoftOx Solutions AS for how efficiently the company converts equity into cash flow.
SoftOx Solutions AS - Asset Composition Analysis
Current Asset Composition (December 2025)
SoftOx Solutions AS's total assets of Nkr33.93 Million consist of 58.3% current assets and 41.7% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 58.3% |
| Accounts Receivable | Nkr0.00 | 0.0% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr14.14 Million | 41.7% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how SoftOx Solutions AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore SOFTX working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SoftOx Solutions AS's current assets represent 58.3% of total assets in 2025, an increase from 24.2% in 2016.
- Cash Position: Cash and equivalents constituted 58.3% of total assets in 2025, up from 3.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, a decrease from 68.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 41.7% of total assets.
SoftOx Solutions AS Competitors by Total Assets
Key competitors of SoftOx Solutions AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Savara Inc
NASDAQ:SVRA
|
USA | $192.14 Million |
|
Chengdu Kanghua Biological Products
SHE:300841
|
China | CN¥3.94 Billion |
|
Seegene Inc
KQ:096530
|
Korea | ₩1.22 Trillion |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Shanghai Shen Lian Biomedical Corp
SHG:688098
|
China | CN¥1.53 Billion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $285.41 Million |
|
NervGen Pharma Corp
V:NGEN
|
Canada | CA$13.08 Million |
SoftOx Solutions AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 0.41 | 6.94 |
| Quick Ratio | 1.80 | 0.41 | 6.72 |
| Cash Ratio | 0.00 | 0.41 | 0.00 |
| Working Capital | Nkr8.82 Million | Nkr-15.43 Million | Nkr54.47 Million |
SoftOx Solutions AS - Advanced Valuation Insights
This section examines the relationship between SoftOx Solutions AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.64 |
| Latest Market Cap to Assets Ratio | 0.78 |
| Asset Growth Rate (YoY) | -72.0% |
| Total Assets | Nkr33.93 Million |
| Market Capitalization | $26.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values SoftOx Solutions AS's assets below their book value (0.78x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: SoftOx Solutions AS's assets decreased by 72.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SoftOx Solutions AS (2016–2025)
The table below shows the annual total assets of SoftOx Solutions AS from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr33.93 Million ≈ $3.57 Million |
-71.99% |
| 2024-12-31 | Nkr121.14 Million ≈ $12.75 Million |
+24.58% |
| 2023-12-31 | Nkr97.24 Million ≈ $10.23 Million |
+24.93% |
| 2022-12-31 | Nkr77.83 Million ≈ $8.19 Million |
-27.38% |
| 2021-12-31 | Nkr107.18 Million ≈ $11.28 Million |
+22.75% |
| 2020-12-31 | Nkr87.31 Million ≈ $9.19 Million |
-16.82% |
| 2019-12-31 | Nkr104.96 Million ≈ $11.05 Million |
+348.69% |
| 2018-12-31 | Nkr23.39 Million ≈ $2.46 Million |
-24.63% |
| 2017-12-31 | Nkr31.04 Million ≈ $3.27 Million |
+250.31% |
| 2016-12-31 | Nkr8.86 Million ≈ $932.31K |
-- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx So… Read more